Document Detail

Barriers to implementing a surgical beta-blocker protocol.
MedLine Citation:
PMID:  16335065     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Experience with a quality improvement (QI) program undertaken to increase the use of beta-adrenergic blockade in at-risk patients at both a major academic medical center and a community hospital suggests barriers to implementation. METHODS: A retrospective and prospective cohort study was performed to establish the incidence and effectiveness of beta-blockade use pre- and postimplementation of a standardized screening tool and a major education program as part of a QI project. Data gathering involved a baseline phase pre-intervention; 6 weeks postintervention; and 3-6 months postintervention. RESULTS: During phase I (baseline) 56% of eligible received beta-blockers, but targeted measures (a pre-induction heart rate < 70 or a systolic blood pressure [BP] < 110 mmHg) were achieved in only 11% of patients. Phase II saw a significant overall increase in beta-blocker administration (79%) and efficacy (50%). However, during phase III (3-6 months postimplementation), the rate of beta-blocker administration fell to 61% overall, while overall efficacy remained stable at 52%. Significant differences between the academic and community hospitals were observed throughout the study. CONCLUSION: Implementation of a quality program for beta-blockade is significantly affected by the presence or absence of ongoing physician and staff education beyond the study period.
Michael N Cantor; Valentina Lavarias; Steven Lam; Lauren Mount; Violetta Laskova; Vadim Nakhamiyayev; Yakov Bier; Dino Paiusco; Anthony C Antonacci
Related Documents :
10204815 - Baroreflex sensitivity and the blood pressure response to beta-blockade.
6256045 - Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic re...
41475 - Labetalol as a hypotensive agent in otological operations.
9385755 - Study of pressure pain and cellular concentration of neurotransmitters related to nocic...
3305465 - Cardiac, respiratory, and renal responses to stimulation of the external cuneate nucleus.
19249925 - Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage f...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Joint Commission journal on quality and patient safety / Joint Commission Resources     Volume:  31     ISSN:  1553-7250     ISO Abbreviation:  -     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-12-09     Completed Date:  2006-01-31     Revised Date:  2006-08-28    
Medline Journal Info:
Nlm Unique ID:  101238023     Medline TA:  Jt Comm J Qual Patient Saf     Country:  United States    
Other Details:
Languages:  eng     Pagination:  640-8     Citation Subset:  IM    
Department of Medicine, Beth Israel Medical Center, New York City, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Academic Medical Centers
Adrenergic beta-Antagonists / administration & dosage,  therapeutic use*
Cardiac Output, Low / drug therapy
Clinical Protocols*
Cohort Studies
Diffusion of Innovation*
Dose-Response Relationship, Drug
Hospitals, Community
Postanesthesia Nursing*
Prospective Studies
Retrospective Studies
Treatment Outcome
Reg. No./Substance:
0/Adrenergic beta-Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Drivers of electronic medical record adoption among medical groups.
Next Document:  A review of the factors affecting the survival of donkeys in semi-arid regions of sub-Saharan Africa...